Clinical Trial Update: A Trial Investigating the Pharmacokinetics and Pharmacodynamics of rFVIIa in Patients With Haemophilia A or B With or Without Inhibitors [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetics and pharmacodynamics study of recombinant factor VIIa in patients with Haemophilia A or Haemophilia B, with or without inhibitors, has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Haemophilia

Drugs mentioned

• NovoSeven RT (Recombinant activated factor VII)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Congenital Bleeding Disorder, Haemophilia A | Phase 1 | Status: COMPLETED